Using Diamond's XChem platform to study the structure of proteins in SARS-CoV-2
Take a look at our most recent case study, which showcases how researchers at UCL harnessed the power of two bioSAXS methods at Diamond. Their objective? To explore the therapeutic potential of nanobodies derived from Llamas.
This groundbreaking research was driven by the goal to discover a cost-effective antibody capable of preventing COVID-19 infections